TransCode Therapeutics Inc. - RNAZ Company Short-Term Debt

Public company logo of TransCode Therapeutics (RNAZ)

TransCode Therapeutics (RNAZ) specializes in oncology treatment via RNA therapy, leveraging the development of the TTX-MS138 delivery system and the pursuit of strategic partners. High costs associated with clinical trials and patent protection create a significant barrier to entry for new players. The price indicator on the GURU.Markets platform chart, where the metric reached 0.00, complements data regarding the implementation of AI and robotics to automate drug synthesis.

RNAZ (TransCode Therapeutics) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for TransCode Therapeutics Inc. (RNAZ)

- price and consensus price forecast:
Stock Quotes TransCode|RNAZ - Analyst Forecast Prices
- market capitalization data:
Market Value TransCode Therapeutics, Inc.|RNAZ - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share TransCode Therapeutics|RNAZ - Book Capitalization|Market Value to Book Value Ratio transcodetherapeutics.com|RNAZ - Total Business Assets
- debt and liquidity data:
Debt to Equity TransCode Therapeutics|RNAZ - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital TransCode|RNAZ - Company Total Debt|Debt to Book Capitalization Ratio TransCode Therapeutics, Inc.|RNAZ - Long-Term Debt|Company Short-Term Debts TransCode Therapeutics
Fundamental company valuation:transcodetherapeutics.com, RNAZ
Product sample of TransCode Therapeutics Inc.

TransCode Therapeutics (RNAZ) is engaged in the capital-intensive development of RNA-based drugs, where intensive clinical trial expenditures place a significant strain on liquidity. This metric aggregates all obligations maturing within one year, allowing investors to assess default risk amid a high cash burn rate, which makes the analysis of current liability trends critical for forecasting the company's financial stability.

Competitors of TransCode Therapeutics (RNAZ)

Company Current Liabilities Tempus AI, Inc TEM|QGEN: Amount of Current Liabilities|Company Short-Term Debt Ionis Pharma IONS|Repligen Inc. (RGEN) - Company Short-Term Loans and Borrowings|RNA (Avidity Biosciences) - Company Short-Term Debts|Company Short-Term Debts CRSP|Company Short-Term Debt GeneDx WGS|Company Short-Term Indebtedness RARE (Ultragenyx Pharmaceutical Inc.)|Company Short-Term Debt BEAM|Short-Term Debt Volume Sarepta Corp SRPT|TWST: Company Short-Term Debts|TXG: Company Current Liabilities|Company Short-Term Debt NTLA|Stoke Therapeutics Inc (STOK) - Short-Term Debt|Company Short-Term Debts BioLife Corp (BLFS)|Company Short-Term Indebtedness Wave Pharma|Maze Therapeutics Inc - Company Short-Term Debts|Short-Term Debt sionnatx.com SION|Company Current Liabilities Prime Medicine|TSHA - Company Short-Term Loans and Borrowings|Company Current Liabilities uniQure Corp QURE|MGTX - Amount of Current Liabilities|Company Short-Term Debts REGENXBIO Inc. RGNX|solidbio.com (SLDB) - Company Short-Term Loans and Borrowings|Company Short-Term Debts OCGN (Ocugen)|Short-Term Debt PACB|Benitec (BNTC) - Company Short-Term Debt|Company Short-Term Loans and Borrowings Design Corp (DSGN)|Company Short-Term Debts RCKT (Rocket Pharmaceuticals)|4dmoleculartherapeutics.com - Company Short-Term Debts|Company Short-Term Debt Lexeo|KRRO - Current Liabilities|Company Short-Term Debts EDIT|Short-Term Debt Silence Therapeutics Corp|PRQR (ProQR) - Company Current Liabilities|Company Short-Term Debts Codexis Bio (CDXS)|Company Current Liabilities Sangamo Therapeutics, Inc.|Amount of Current Liabilities nautilus.bio (NAUT)|Company Short-Term Debts MGX|Short-Term Debt Volume precisionbiosciences.com DTIL|GBIO: Company Short-Term Debts|BOLD: Company Current Liabilities|exicuretx.com - Company Short-Term Debt|IMNN (Imunon) - Short-Term Debt Volume|PHIO - Company Short-Term Debt|Company Short-Term Loans and Borrowings MBIO|Company Short-Term Debt Bionano Genomics, Inc. BNGO|Company Short-Term Indebtedness adnas.com (APDN)|Company Short-Term Debts BLUE (bluebird bio)|IPA - Company Short-Term Debts|Company Current Liabilities Omega|OMIC - Current Liabilities|Company Short-Term Debts Regulus Therapeutics|SYRS (syros.com) - Company Short-Term Indebtedness|Company Short-Term Debt Telesis Bio (TBIO)|Company Short-Term Indebtedness TRACON Pharmaceuticals Inc.|Company Short-Term Debts UBX